Kymera Therapeutics Inc. (KYMR)

KYMR trades at $46.99, 17.5% above the near-term max pain of $40 expiring Sep 19, 2025 (6 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($30-$40), signaling increased put positioning or downside protection. Key magnetic zone at 40 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KYMR shows a downward trend from 40 to 30, indicating bearish sentiment or hedging activity. The 26% spread signals divergent expectations across timeframes. Most levels below 46.99 may cap rallies. Strong magnetic level at 40 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.